Breast Cancer pp 267-281 | Cite as

Special Problems in the Management of Advanced Breast Cancer

  • B. M. Healey
  • D. C. Tormey
Part of the UICC International Union Against Cancer book series (1360)

Abstract

Breast Cancer is a systemic disease at the time a clinical diagnosis is established in the majority of patients. This concept is the basis of current efforts to improve survival with adjuvant systemic therapy. Similarly, patients with recurrent breast cancer can be assumed to have widely disseminated disease when the recurrence is first diagnosed. Many of these patients will develop problems related to individual sites of metastases. In this chapter, we examine some of the problems encountered in the management of patients with specific sites of metastatic involvement.

Keywords

Osteoporosis Radioactive Isotope Dexamethasone Prostaglandin Methotrexate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further Reading

  1. 1.
    Spiegel D, Bloom JR (1983) Pain in metastatic breast cancer. Cancer 52:341–345PubMedCrossRefGoogle Scholar
  2. 2.
    Coleman RE, Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55:61–66PubMedCrossRefGoogle Scholar
  3. 3.
    Ingle JN, Tormey DC, Tan HK (1978) The bone marrow examination in breast cancer: diagnostic considerations and clinical usefulness. Cancer 41:670–674PubMedCrossRefGoogle Scholar
  4. 4.
    Mundy GR, Wilkinson R, Heath DA (1983) Comparative study of available medical treatment for hypercalcemia of malignancy. Am J Med 74:421–432PubMedCrossRefGoogle Scholar
  5. 5.
    Mountain CF, McMurtry MJ, Hermes KE (1984) Surgery for pulmonary metastases: a twenty-year experience. Ann Thorac Surg 38:323–330PubMedCrossRefGoogle Scholar
  6. 6.
    Green N, Keen W, Levis R, Schleiter W, Bonorris J, Berne CJ (1977) Lymphangitic carcinomatosis of the lung: pathologic diagnostic and treatment considerations. Int J Radiat Oncol Bio Phys 2:149–153Google Scholar
  7. 7.
    Fentimen IS, Rubens RD, Hayward JL (1983) Control of pleural effusion in patients with breast cancer: a randomized trial. Cancer 52:737–739CrossRefGoogle Scholar
  8. 8.
    Reshad K, Inue K, Takeuchi Y, Takahashi Y, Hitomi S (1985) Treatment of malignant pleural effusions. Chest 88:393–397PubMedCrossRefGoogle Scholar
  9. 9.
    Hendrickson FR (1977) The optimal schedule for palliative radiotherapy for metastatic brain cancer. Int J Radiat Oncol Bio Phys 2:165–168Google Scholar
  10. 10.
    Sculier JP (1985) Treatment of meningeal carcinomatosis. Cancer Treat Rev 12:95–104PubMedCrossRefGoogle Scholar
  11. 11.
    Rodriguez M, Dinapoli RP (1980) Spinal cord compression with special reference to metastatic epidural tumors. Mayo Clin Proc 55:442–448PubMedGoogle Scholar
  12. 12.
    Rosner D, Nemoto T, Lane WW (1986) Chemotherapy-induced regression of brain metastases in breast cancer. Cancer 58:832–839PubMedCrossRefGoogle Scholar
  13. 13.
    Greenberg HS, Kim JH, Posner JB (1980) Epidural spinal cord compression from metastatic tumor results with a new treatment protocol. Ann Neurol 8:361–366PubMedCrossRefGoogle Scholar
  14. 14.
    Bullock JD et al. (1980) Ophthalmic manifestations of metastatic breast cancer. Ophthalmol 87:961–973Google Scholar
  15. 15.
    Feun LG, Dreilichman A, Singhekowinta A, Vaitkevicius VK (1979) Ureteral obstruction secondary to metastatic breast cancer. Cancer 44:1164–1171PubMedCrossRefGoogle Scholar
  16. 16.
    Bitran JP, Evans R, Brown C (1984) The management of cardiac tamponade in patients with breast cancer. J Surg Oncol 27:42–44PubMedCrossRefGoogle Scholar
  17. 17.
    Buck M, Ingle JN, Guiliani ER, Gordon JR, Therneau TM (1987) Pericardial effusion in women with breast cancer. Cancer 60:263–269PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • B. M. Healey
  • D. C. Tormey

There are no affiliations available

Personalised recommendations